PGNYProgyny, Inc.

$1B

Q1 2024 Earnings

Healthcare Medical - Healthcare Information Services

Income Statement

Revenue

$278M+7.6% YoY

Gross Profit

$62M22.4% margin

Operating Income

$19M6.7% margin

Net Income

$17M6.1% margin

EPS (Diluted)

$0.17

QoQ Revenue Growth

+3.0%

Cash Flow

Operating Cash Flow

$26M

Free Cash Flow

$25M

Stock-Based Comp.

$31M

Balance Sheet

Total Assets

$794M

Total Liabilities

$223M

Stockholders' Equity

$572M

Cash & Equivalents

$115M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$278M	$258M	+7.6%
Gross Profit	$62M	$59M	+6.4%
Operating Income	$19M	$15M	+23.4%
Net Income	$17M	$18M	-4.4%

Revenue Segments

Fertility benefit services revenue

$170M61%

Pharmacy benefit services revenue

$108M39%

PGNY Q1 2024 Earnings — Progyny, Inc. Revenue & Financial Results | Market Cap Arena